Search results for carcinoma

4073 hits were found for carcinoma

# Family MCID Name MIFTS Score
1
P HPT023 Hepatocellular Carcinoma 94 5.030
2
SQM006 Squamous Cell Carcinoma 74 4.971
3
RNL114 Renal Cell Carcinoma, Nonpapillary 68 4.965
4
RNL065 Renal Cell Carcinoma, Papillary, 1 56 3.734
5
P THY109 Thyroid Cancer, Nonmedullary, 1 64 3.597
6
SQM013 Squamous Cell Carcinoma, Head and Neck 79 3.490
7
ADR054 Adrenocortical Carcinoma, Hereditary 63 3.490
8
THY111 Thyroid Carcinoma, Familial Medullary 63 3.433
9
P BRS047 Breast Cancer 100 3.316
10
P PNC035 Pancreatic Cancer 89 3.108
11
P NSP012 Nasopharyngeal Carcinoma 71 3.106
12
c BSL007 Basal Cell Carcinoma 66 3.077
13
CLL002 Collecting Duct Carcinoma 43 2.969
14
PRT010 Parathyroid Carcinoma 64 2.786
15
TRN018 Transitional Cell Carcinoma 58 2.761
16
MRK001 Merkel Cell Carcinoma 59 2.761
17
c BSL024 Basal Cell Carcinoma 1 42 2.759
18
P LNG032 Lung Cancer 99 2.737
19
ESP021 Esophageal Cancer 79 2.661
20
c THY102 Thyroid Cancer, Nonmedullary, 2 57 2.612
21
SLV012 Salivary Gland Adenoid Cystic Carcinoma 54 2.588
22
P RNL003 Renal Clear Cell Carcinoma 58 2.546
23
ORL015 Oral Squamous Cell Carcinoma 59 2.521
24
P SML001 Small Cell Carcinoma 58 2.428
25
c SML038 Small Cell Cancer of the Lung 67 2.423
26
END057 Endometrial Cancer 76 2.360
27
FBR086 Fibrolamellar Carcinoma 50 2.318
28
CHR177 Chromophobe Renal Cell Carcinoma 59 2.303
29
CRV038 Cervical Squamous Cell Carcinoma 61 2.269
30
EMB004 Embryonal Carcinoma 59 2.248
31
P CLR023 Colorectal Cancer 98 2.234
32
P BLD134 Bladder Cancer 78 2.229
33
THY096 Thyroid Carcinoma, Hurthle Cell 27 2.207
34
ADN009 Adenosquamous Carcinoma 54 2.142
35
PPL002 Papillary Carcinoma 51 2.131
36
P PRN020 Paranasal Sinus Cancer 44 2.124
37
BLD131 Bladder Urothelial Carcinoma 55 2.121
38
BSL036 Basal Cell Nevus Syndrome 67 2.100
39
MCP006 Mucoepidermoid Carcinoma 51 2.085
40
EPT010 Epithelial-Myoepithelial Carcinoma 48 2.061
41
CHL128 Childhood Hepatocellular Carcinoma 47 2.060
42
NDL009 Nodular Basal Cell Carcinoma 36 2.045
43
GST053 Gastric Cancer 84 1.982
44
c OVR114 Ovarian Cancer 1 54 1.967
45
ACN001 Acinar Cell Carcinoma 52 1.959
46
RNL119 Renal Cell Carcinoma, Xp11-Associated 30 1.946
47
SPP010 Suppressor of Tumorigenicity 3 55 1.934
48
SML031 Small Cell Carcinoma of the Bladder 34 1.933
49
LNG039 Lung Squamous Cell Carcinoma 60 1.925
50
BRS099 Breast Ductal Carcinoma 55 1.925
51
ANL011 Anal Canal Carcinoma 36 1.921
52
c PRM126 Primary Peritoneal Carcinoma 59 1.912
53
TYL002 Tylosis with Esophageal Cancer 28 1.902
54
CLR030 Clear Cell Renal Cell Carcinoma 55 1.901
55
P LRY044 Larynx Cancer 57 1.899
56
DCT002 Ductal Carcinoma in Situ 56 1.897
57
SPR005 Superficial Basal Cell Carcinoma 40 1.886
58
BRS062 Breast Secretory Carcinoma 35 1.879
59
P PRS040 Prostate Cancer 88 1.853
60
SRC008 Sarcomatoid Squamous Cell Skin Carcinoma 31 1.851
61
CRV040 Cervix Carcinoma 52 1.848
62
VLV034 Vulva Squamous Cell Carcinoma 31 1.845
63
LNG017 Lung Giant Cell Carcinoma 39 1.843
64
BSL044 Basal Cell Carcinoma, Infundibulocystic 27 1.825
65
CRV002 Cervix Uteri Carcinoma in Situ 40 1.824
66
SPN032 Spindle Cell Carcinoma 43 1.791
67
BRS056 Breast Metaplastic Carcinoma 38 1.786
68
BSS001 Basosquamous Carcinoma 26 1.786
69
LYM006 Lymphoepithelioma-Like Carcinoma 46 1.786
70
P OVR042 Ovarian Cancer 82 1.781
71
c OVR058 Ovarian Small Cell Carcinoma 31 1.773
72
PNC008 Pancreatic Endocrine Carcinoma 40 1.758
73
AMP003 Ampulla of Vater Neoplasm 39 1.758
74
TNG009 Tongue Squamous Cell Carcinoma 57 1.745
75
P CHR573 Choroid Plexus Cancer 46 1.739
76
BSL006 Basaloid Squamous Cell Carcinoma 43 1.721
77
END002 Endometrioid Ovary Carcinoma 34 1.718
78
PNS010 Penis Squamous Cell Carcinoma 19 1.718
79
PLM173 Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and 46,xx Sex Reversal 22 1.707
80
c LRG001 Large Cell Carcinoma 50 1.699
81
END015 Endometrial Adenosquamous Carcinoma 26 1.697
82
RCT023 Rectum Squamous Cell Carcinoma 19 1.697
83
PTT008 Pituitary Carcinoma 51 1.691
84
ANL008 Anal Carcinoma in Situ 22 1.679
85
GLL018 Gallbladder Cancer 67 1.677
86
ADR005 Adrenal Carcinoma 59 1.672
87
THY025 Thymus Cancer 52 1.666
88
VLV032 Vulva Cancer 47 1.657
89
NRN004 Neuroendocrine Tumor 58 1.655
90
BRS063 Breast Squamous Cell Carcinoma 33 1.654
91
PLM009 Pleomorphic Adenoma Carcinoma 28 1.652
92
BLD047 Bladder Squamous Cell Carcinoma 43 1.649
93
BRS032 Breast Papillary Carcinoma 31 1.644
94
GST028 Gastric Squamous Cell Carcinoma 37 1.637
95
CNJ018 Conjunctival Squamous Cell Carcinoma 28 1.632
96
CTN009 Cutaneous Adenocystic Carcinoma 30 1.629
97
MRP002 Morpheaform Basal Cell Carcinoma 27 1.624
98
PNC013 Pancreatic Ductal Carcinoma 47 1.622
99
DFF036 Differentiated Thyroid Carcinoma 49 1.621
100
BLD034 Bile Duct Carcinoma 60 1.621
101
THY049 Thyroid Cancer, Anaplastic 53 1.617
102
ANL017 Anal Squamous Cell Carcinoma 49 1.606
103
c INS002 in Situ Carcinoma 56 1.604
104
HRD029 Hereditary Leiomyomatosis and Renal Cell Cancer 57 1.602
105
EMB006 Embryonal Testis Carcinoma 25 1.600
106
SKN022 Skin Squamous Cell Carcinoma 46 1.594
107
FLL027 Fallopian Tube Carcinoma 62 1.593
108
MTT001 Metatypical Basal Cell Carcinoma 19 1.592
109
GST071 Gastrointestinal Carcinoma 40 1.589
110
ESP027 Esophagus Squamous Cell Carcinoma 45 1.587
111
THY028 Thyroid Cancer 72 1.577
112
P OVR106 Ovarian Clear Cell Carcinoma 45 1.575
113
CRB006 Cribriform Carcinoma 41 1.574
114
P BRN120 Bronchus Cancer 39 1.570
115
CRV013 Cervical Adenoid Cystic Carcinoma 14 1.568
116
CLN009 Colon Squamous Cell Carcinoma 20 1.562
117
P CNT003 Central Nervous System Embryonal Carcinoma 10 1.559
118
P PNL012 Penile Cancer 58 1.548
119
NTM002 Nut Midline Carcinoma 38 1.544
120
BLR007 Biliary Tract Neoplasm 53 1.540
121
ADN013 Adenoid Squamous Cell Carcinoma 30 1.538
122
KRT003 Keratinizing Squamous Cell Carcinoma 37 1.533
123
FML037 Female Breast Cancer 52 1.529
124
CRV022 Cervix Small Cell Carcinoma 38 1.528
125
APC004 Apocrine Adenocarcinoma 38 1.521
126
BRT045 Bartholin's Gland Benign Neoplasm 35 1.521
127
CHL065 Cholangiocarcinoma 70 1.520
128
c BSL011 Basal Cell Carcinoma, Multiple 34 1.515
129
SGN002 Signet Ring Cell Adenocarcinoma 47 1.514
130
BRS023 Breast Adenoid Cystic Carcinoma 36 1.503
131
NSL006 Nasal Cavity Squamous Cell Carcinoma 35 1.499
132
PRS004 Prostate Squamous Cell Carcinoma 27 1.492
133
CRV033 Cervical Adenosquamous Carcinoma 43 1.490
134
URT051 Ureter, Cancer of 43 1.490
135
END029 Endocervical Carcinoma 20 1.483
136
c SKN012 Skin Carcinoma in Situ 33 1.480
137
PRS008 Prostate Small Cell Carcinoma 25 1.480
138
P LRG014 Large Cell Neuroendocrine Carcinoma 37 1.477
139
c BRS049 Breast Carcinoma in Situ 55 1.475
140
c INF023 Inflammatory Breast Carcinoma 54 1.473
141
SRC002 Sarcomatoid Renal Cell Carcinoma 42 1.472
142
LNG011 Lung Adenoid Cystic Carcinoma 40 1.470
143
OCL009 Ocular Cancer 61 1.466
144
P LNG035 Lung Large Cell Carcinoma 34 1.466
145
CTN002 Cutaneous Mucoepidermoid Carcinoma 19 1.463
146
MDD009 Middle Ear Carcinoma 25 1.459
147
ANL016 Anal Margin Carcinoma 20 1.459
148
MDD007 Middle Ear Squamous Cell Carcinoma 24 1.454
149
THY116 Thyroid Carcinoma, Nonmedullary, with or Without Cell Oxyphilia 17 1.452
150
SRC007 Sarcomatoid Transitional Cell Carcinoma 16 1.446
151
P DFF019 Diffuse Gastric Cancer 43 1.444
152
OVR050 Ovarian Embryonal Carcinoma 41 1.444
153
RNL009 Renal Pelvis Squamous Cell Carcinoma 14 1.444
154
GLL015 Gallbladder Squamous Cell Carcinoma 27 1.441
155
TRC014 Trachea Adenoid Cystic Carcinoma 16 1.438
156
CLN004 Colon Carcinoma in Situ 35 1.435
157
ADN006 Adenosquamous Colon Carcinoma 32 1.435
158
BRS057 Breast Mucinous Carcinoma 25 1.435
159
c STM003 Stomach Carcinoma in Situ 17 1.435
160
TRC017 Trachea Squamous Cell Carcinoma 14 1.435
161
MXL002 Maxillary Sinus Adenoid Cystic Carcinoma 24 1.432
162
EXT023 External Ear Carcinoma 12 1.428
163
ESP005 Esophagus Carcinoma in Situ 10 1.428
164
EXC001 Exocervical Carcinoma 9 1.428
165
c NSL007 Nasal Cavity Carcinoma in Situ 9 1.428
166
PRS019 Prostate Adenoid Cystic Carcinoma 15 1.425
167
ANS001 Anus Basaloid Carcinoma 14 1.425
168
c BSL034 Basal Cell Carcinoma 7 13 1.425
169
GLT004 Glottis Squamous Cell Carcinoma 12 1.421
170
PNC042 Pancreatic Intraductal Papillary-Colloid Carcinoma 10 1.421
171
LNG007 Lung Mixed Small Cell and Squamous Cell Carcinoma 9 1.421
172
CCL003 Cecal Benign Neoplasm 22 1.413
173
PGM002 Pigmented Basal Cell Carcinoma 28 1.410
174
CLC003 Cloacogenic Carcinoma 35 1.408
175
ADN008 Adenosquamous Pancreas Carcinoma 38 1.392
176
GLY012 Glycogen-Rich Clear Cell Breast Carcinoma 30 1.391
177
ADN015 Adenoid Basal Cell Carcinoma 30 1.382
178
RCT018 Rectal Neoplasm 53 1.378
179
PPL007 Papillary Serous Adenocarcinoma 45 1.374
180
GST015 Gastric Small Cell Carcinoma 30 1.370
181
OVR005 Ovarian Large-Cell Neuroendocrine Carcinoma 21 1.367
182
PLM177 Pilomatrix Carcinoma 22 1.362
183
END025 Endometrial Squamous Cell Carcinoma 39 1.361
184
c SML034 Small Cell Neuroendocrine Carcinoma 39 1.360
185
LRY011 Larynx Verrucous Carcinoma 31 1.358
186
BRS042 Breast Scirrhous Carcinoma 32 1.353
187
SCR016 Scrotal Carcinoma 35 1.349
188
MYP001 Myoepithelioma 42 1.346
189
BRS015 Breast Medullary Carcinoma 31 1.344
190
PLM016 Pleomorphic Carcinoma 38 1.344
191
c MLG049 Malignant Syringoma 29 1.343
192
BLD005 Bile Duct Mucoepidermoid Carcinoma 27 1.343
193
c HRD020 Hereditary Renal Cell Carcinoma 25 1.343
194
GLL007 Gallbladder Small Cell Carcinoma 22 1.343
195
RNL018 Renal Pelvis Carcinoma 34 1.339
196
BZX001 Bazex Syndrome 43 1.337
197
URN001 Urinary Bladder Small Cell Neuroendocrine Carcinoma 20 1.337
198
BRS010 Breast Mucoepidermoid Carcinoma 24 1.333
199
GST008 Gastric Adenosquamous Carcinoma 30 1.331
200
MXL004 Maxillary Sinus Squamous Cell Carcinoma 28 1.331
201
P BRS026 Breast Apocrine Carcinoma 18 1.331
202
ESP010 Esophageal Basaloid Squamous Cell Carcinoma 36 1.329
203
EYL001 Eyelid Neoplasm 27 1.329
204
URT013 Ureter Small Cell Carcinoma 16 1.327
205
c MLN043 Melanoma, Cutaneous Malignant 8 26 1.323
206
LCR006 Lacrimal Gland Adenoid Cystic Carcinoma 28 1.321
207
LNG019 Lung Combined Type Small Cell Carcinoma 22 1.321
208
BRS037 Breast Cystic Hypersecretory Carcinoma 18 1.319
209
ANL004 Anal Canal Squamous Cell Carcinoma 40 1.317
210
P NSL008 Nasal Cavity Cancer 38 1.317
211
FML029 Familial Renal Papillary Carcinoma 36 1.317
212
SCH010 Schneiderian Carcinoma 26 1.317
213
LCR011 Lacrimal Gland Carcinoma 25 1.317
214
ADN007 Adenosquamous Prostate Carcinoma 14 1.317
215
INV004 Invasive Bladder Transitional Cell Carcinoma 37 1.315
216
ADN005 Adenosquamous Gallbladder Carcinoma 23 1.312
217
CLR015 Clear Cell Basal Cell Carcinoma 21 1.312
218
AML004 Ameloblastic Carcinoma 35 1.308
219
CHL010 Childhood Kidney Cell Carcinoma 37 1.307
220
GST041 Gastric Cardia Carcinoma 26 1.307
221
VLV002 Vulva Basal Cell Carcinoma 25 1.307
222
END018 Endometrium Carcinoma in Situ 16 1.307
223
MCP008 Mucoepidermoid Esophageal Carcinoma 19 1.305
224
TRC025 Tracheal Cancer 37 1.302
225
SRC003 Sarcomatoid Basal Cell Carcinoma 12 1.299
226
RNL019 Renal Pelvis Transitional Cell Carcinoma 18 1.297
227
SQM020 Squamous Cell Carcinoma of the Pancreas 14 1.297
228
THY010 Thymus Mucoepidermoid Carcinoma 14 1.297
229
SNN002 Sinonasal Undifferentiated Carcinoma 31 1.295
230
RTR004 Retroperitoneum Carcinoma 31 1.294
231
THY065 Thyroid Carcinoma, Papillary, with Papillary Renal Neoplasia 23 1.294
232
LCR002 Lacrimal Gland Mucoepidermoid Carcinoma 14 1.294
233
LRY005 Laryngeal Small Cell Carcinoma 12 1.294
234
PRS027 Prostate Transitional Cell Carcinoma 21 1.291
235
LYM018 Lymphoepithelioma-Like Thymic Carcinoma 20 1.291
236
P THY005 Thymus Large Cell Carcinoma 13 1.291
237
SBC011 Sebaceous Adenocarcinoma 41 1.288
238
FRN005 Frontal Sinus Squamous Cell Carcinoma 11 1.288
239
PNS002 Penis Carcinoma in Situ 16 1.284
240
URT028 Ureter Transitional Cell Carcinoma 15 1.284
241
FLL017 Fallopian Tube Squamous Cell Carcinoma 15 1.284
242
c NSP009 Nasopharyngeal Carcinoma 2 15 1.284
243
c BSL028 Basal Cell Carcinoma 5 12 1.284
244
ESP012 Esophageal Adenoid Cystic Carcinoma 12 1.284
245
c PRS031 Prostate Carcinoma in Situ 18 1.281
246
c LRY009 Larynx Carcinoma in Situ 14 1.281
247
ANL007 Anal Margin Squamous Cell Carcinoma 13 1.281
248
TRC002 Trachea Carcinoma in Situ 11 1.281
249
c BSL025 Basal Cell Carcinoma 2 11 1.281
250
SKN011 Skin Pilomatrix Carcinoma 22 1.277
251
LNG002 Lung Combined Large Cell Neuroendocrine Carcinoma 12 1.277
252
EHR001 Ehrlich Tumor Carcinoma 11 1.277
253
c BSL026 Basal Cell Carcinoma 3 11 1.277
254
c BSL027 Basal Cell Carcinoma 4 11 1.277
255
c BSL029 Basal Cell Carcinoma 6 11 1.277
256
HGH030 High-Grade Neuroendocrine Carcinoma of the Cervix Uteri 10 1.277
257
CHL026 Childhood Ovarian Embryonal Carcinoma 9 1.277
258
CHL043 Childhood Embryonal Testis Carcinoma 9 1.277
259
SPR015 Supraglottis Verrucous Carcinoma 9 1.277
260
GST025 Gastric Body Carcinoma 11 1.273
261
SBG003 Subglottis Verrucous Carcinoma 8 1.273
262
LNG012 Lung Occult Squamous Cell Carcinoma 8 1.273
263
HGH029 High-Grade Neuroendocrine Carcinoma of the Corpus Uteri 8 1.273
264
ETH002 Ethmoid Sinus Adenoid Cystic Carcinoma 8 1.273
265
ANL013 Anal Margin Basal Cell Carcinoma 8 1.273
266
GLT003 Glottis Verrucous Carcinoma 7 1.273
267
EXT016 External Ear Squamous Cell Carcinoma 7 1.273
268
INF029 Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant 7 1.273
269
CRN001 Cornea Squamous Cell Carcinoma 7 1.273
270
SCR013 Scrotum Squamous Cell Carcinoma 7 1.273
271
EXT018 External Ear Basal Cell Carcinoma 7 1.273
272
LCR007 Lacrimal Gland Squamous Cell Carcinoma 7 1.273
273
PLM038 Pulmonary Large Cell Neuroendocrine Carcinoma 33 1.244
274
END041 Endometrial Adenocarcinoma 59 1.232
275
HDR006 Hidradenocarcinoma 47 1.227
276
c BLD008 Bladder Carcinoma in Situ 33 1.227
277
c PNL017 Penile Cancer, Adult 22 1.227
278
INF027 Infiltrative Basal Cell Carcinoma 26 1.220
279
LPD003 Lipid-Rich Carcinoma 31 1.218
280
MLT165 Multilocular Cystic Renal Neoplasm of Low Malignant Potential 18 1.217
281
CHL040 Cholangiolocellular Carcinoma 30 1.216
282
TNG003 Tongue Cancer 63 1.214
283
LBL001 Lobular Neoplasia 42 1.214
284
MXD014 Mixed Ductal-Endocrine Carcinoma 29 1.197
285
ONC001 Oncocytic Breast Carcinoma 29 1.194
286
SYN003 Synchronous Bilateral Breast Carcinoma 41 1.189
287
CYS004 Cystic Basal Cell Carcinoma 22 1.187
288
END013 Endometrial Small Cell Carcinoma 28 1.182
289
MCN004 Mucinous Tubular and Spindle Renal Cell Carcinoma 27 1.179
290
P GRN010 Granular Cell Tumor 47 1.177
291
INT041 Intratubular Embryonal Carcinoma 27 1.177
292
KRK001 Krukenberg Carcinoma 30 1.175
293
VLV049 Vulvar Basal Cell Carcinoma 12 1.170
294
CMD001 Comedo Carcinoma 27 1.168
295
ESP006 Esophageal Adenosquamous Carcinoma 20 1.166
296
OVR027 Ovarian Squamous Cell Carcinoma 23 1.162
297
BRN015 Bronchiolo-Alveolar Adenocarcinoma 46 1.160
298
GST042 Gastric Diffuse Adenocarcinoma 26 1.160
299
ESP011 Esophagus Verrucous Carcinoma 11 1.160
300
ADN010 Adenosquamous Cell Lung Carcinoma 45 1.151
301
SQM012 Squamous Cell Carcinoma of the Corpus Uteri 10 1.146
302
DST001 Distal Biliary Tract Carcinoma 14 1.144
303
PLM156 Palmoplantar Carcinoma, Multiple Self-Healing 33 1.141
304
TNS013 Tonsil Squamous Cell Carcinoma 22 1.141
305
SCR014 Scrotum Basal Cell Carcinoma 12 1.141
306
ADR004 Adrenal Cortical Adenocarcinoma 47 1.139
307
FML211 Familial Papillary or Follicular Thyroid Carcinoma 25 1.138
308
SCL007 Sclerosing Hepatic Carcinoma 25 1.136
309
LRY010 Laryngeal Adenoid Cystic Carcinoma 11 1.133
310
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 41 1.130
311
LNG091 Lung Mucoepidermoid Carcinoma 24 1.130
312
SPR023 Supraglottis Squamous Cell Carcinoma 17 1.130
313
UND009 Undifferentiated Carcinoma of Stomach 16 1.130
314
MCR016 Micronodular Basal Cell Carcinoma 12 1.130
315
MCP007 Mucoepidermoid Thyroid Carcinoma 17 1.127
316
c NSP015 Nasopharyngeal Carcinoma 3 17 1.127
317
PPL014 Papillary Transitional Carcinoma 12 1.127
318
LRG005 Large Cell Carcinoma with Rhabdoid Phenotype 21 1.124
319
THY027 Thymus Squamous Cell Carcinoma 13 1.124
320
PPL004 Papillary Squamous Carcinoma 10 1.124
321
BNC003 Bone Cancer 59 1.120
322
MLN047 Melanoma-Pancreatic Cancer Syndrome 22 1.120
323
HPT011 Hepatocellular Clear Cell Carcinoma 12 1.120
324
TLL001 Tall Cell Variant Papillary Carcinoma 11 1.120
325
CLN008 Colon Small Cell Carcinoma 13 1.117
326
MCR015 Microinvasive Cervical Squamous Cell Carcinoma 11 1.117
327
THY011 Thymus Basaloid Carcinoma 10 1.117
328
HYP053 Hypercalcemic Type Ovarian Small Cell Carcinoma 9 1.117
329
LRY003 Laryngeal Mucoepidermoid Carcinoma 9 1.117
330
c THY008 Thymus Small Cell Carcinoma 9 1.117
331
CRV012 Cervical Verrucous Carcinoma 8 1.117
332
ADR035 Adrenocortical Carcinoma with Pure Aldosterone Hypersecretion 19 1.113
333
MLT005 Multicentric Papillary Thyroid Carcinoma 16 1.113
334
OVR026 Ovary Transitional Cell Carcinoma 12 1.113
335
ETH003 Ethmoid Sinus Squamous Cell Carcinoma 9 1.113
336
THY012 Thymus Adenosquamous Carcinoma 9 1.113
337
RCT010 Rectum Carcinoma in Situ 9 1.113
338
LVR003 Liver Carcinoma in Situ 8 1.113
339
GLL004 Gallbladder Papillary Carcinoma 8 1.113
340
END024 Endometrial Transitional Cell Carcinoma 11 1.109
341
URT034 Urethra Squamous Cell Carcinoma 11 1.109
342
ADN003 Adenosquamous Bile Duct Carcinoma 10 1.109
343
BRT008 Bartholin's Gland Adenoid Cystic Carcinoma 9 1.109
344
BSL002 Basaloid Squamous Cell Skin Carcinoma 8 1.109
345
ADN062 Adenoid Basal Carcinoma of the Cervix Uteri 7 1.109
346
NNN001 Nonencapsulated Sclerosing Carcinoma 7 1.109
347
ESP004 Esophagus Small Cell Carcinoma 7 1.109
348
SRC005 Sarcomatoid Penile Squamous Cell Carcinoma 7 1.109
349
BRT006 Bartholin's Gland Adenosquamous Carcinoma 6 1.109
350
TRN048 Transitional Cell Carcinoma of the Corpus Uteri 6 1.109
351
URT018 Urethra Transitional Cell Carcinoma 13 1.105
352
UND008 Undifferentiated Carcinoma of Esophagus 12 1.105
353
URT021 Ureter Squamous Cell Carcinoma 10 1.105
354
AMP002 Ampulla of Vater Small Cell Carcinoma 10 1.105
355
BRS014 Breast Signet Ring Cell Adenocarcinoma 10 1.105
356
c THY018 Thymus Clear Cell Carcinoma 9 1.105
357
BRT010 Bartholin's Gland Transitional Cell Carcinoma 8 1.105
358
RCT007 Rectal Cloacogenic Carcinoma 8 1.105
359
KDN011 Kidney Pelvis Sarcomatoid Transitional Cell Carcinoma 8 1.105
360
LNG014 Lung Superior Sulcus Carcinoma 7 1.105
361
P LNG021 Lung Occult Small Cell Carcinoma 7 1.105
362
SPH006 Sphenoid Sinus Squamous Cell Carcinoma 7 1.105
363
c ADL007 Adult Central Nervous System Embryonal Carcinoma 7 1.105
364
KDN008 Kidney Pelvis Papillary Carcinoma 7 1.105
365
SBG004 Subglottis Squamous Cell Carcinoma 7 1.105
366
ACN008 Acantholytic Squamous Cell Skin Carcinoma 7 1.105
367
CLR010 Clear Cell Squamous Cell Skin Carcinoma 7 1.105
368
c BRS033 Breast Apocrine Carcinoma in Situ 7 1.105
369
SGN001 Signet Ring Basal Cell Carcinoma 6 1.105
370
GST022 Gastric Pylorus Carcinoma 6 1.105
371
PDT006 Pediatric Cns Embryonal Cell Carcinoma 6 1.105
372
BRT003 Bartholin's Gland Small Cell Carcinoma 5 1.105
373
BRT007 Bartholin's Gland Squamous Cell Carcinoma 5 1.105
374
UND002 Undifferentiated Carcinoma of the Corpus Uteri 5 1.105
375
FLL021 Follicular Basal Cell Carcinoma 5 1.105
376
CRV029 Cervical Keratinizing Squamous Cell Carcinoma 5 1.105
377
VLV003 Vulvar Basaloid Squamous Cell Carcinoma 5 1.105
378
VLV004 Vulvar Sebaceous Carcinoma 5 1.105
379
DYS002 Dysplastic Nevus Syndrome 36 1.100
380
c MLG048 Malignant Acrospiroma 17 1.100
381
OVR105 Ovarian Serous Carcinoma 43 1.099
382
GST026 Gastric Fundus Cancer 14 1.094
383
PRR005 Paraurethral Gland Cancer 10 1.094
384
PNC010 Pancreatic Signet Ring Cell Adenocarcinoma 10 1.094
385
LBM004 Labium Majus Cancer 9 1.094
386
LBM005 Labia Minora Cancer 9 1.094
387
BLD064 Bladder Cancer, Childhood 7 1.094
388
EPS023 Epstein-Barr Virus-Associated Gastric Carcinoma 42 1.074
389
P KDN017 Kidney Cancer 66 1.071
390
MCN001 Mucinous Adenocarcinoma 54 1.070
391
ORP003 Oropharynx Cancer 51 1.049
392
P LYN001 Lynch Syndrome 71 1.042
393
CLR003 Clear Cell Adenocarcinoma 57 1.029
394
c MLT160 Multiple Endocrine Neoplasia, Type Iia 65 1.021
395
MRT001 Muir-Torre Syndrome 59 1.017
396
PRM205 Primary Hepatic Neuroendocrine Carcinoma 35 1.004
397
c ADL096 Adult Hepatocellular Carcinoma 47 0.993
398
UTR011 Uterine Corpus Serous Adenocarcinoma 43 0.991
399
BLT006 Bilateral Breast Cancer 49 0.988
400
GBL002 Goblet Cell Carcinoid 37 0.988
401
LMN006 Luminal Breast Carcinoma 33 0.985
402
BNS004 Bone Squamous Cell Carcinoma 31 0.983
403
ISL001 Islet Cell Tumor 54 0.975
404
CHR176 Chromophil Renal Cell Carcinoma 19 0.963
405
SQM018 Squamous Cell Carcinoma of the Oral Tongue 27 0.959
406
P TST021 Testicular Germ Cell Tumor 70 0.957
407
PPL058 Papilloma of Choroid Plexus 47 0.952
408
TST014 Testicular Cancer 54 0.947
409
PRM194 Primary Peritoneal Serous/papillary Carcinoma 15 0.947
410
CLL009 Colloid Carcinoma of the Pancreas 28 0.939
411
ACN026 Acinar Cell Carcinoma of Pancreas 25 0.939
412
MXD003 Mixed Lacrimal Gland Cancer 30 0.933
413
PNC053 Pancreatic Islet Cell Tumors 39 0.930
414
ESN003 Eosinophilic Variant of Chromophobe Renal Cell Carcinoma 21 0.930
415
SLD012 Solid Pseudopapillary Carcinoma of the Pancreas 13 0.926
416
P VGN017 Vaginal Cancer 48 0.923
417
MLT003 Multilocular Clear Cell Renal Cell Carcinoma 32 0.923
418
PRT100 Parotid Gland Adenoid Cystic Carcinoma 10 0.923
419
PRL010 Prolactin Producing Pituitary Tumor 41 0.919
420
UTR056 Uterine Corpus Endometrial Carcinoma 24 0.919
421
FBR015 Fibroepithelial Basal Cell Carcinoma 11 0.919
422
c EYC001 Eye Carcinoma in Situ 9 0.919
423
PNS008 Penis Basal Cell Carcinoma 8 0.919
424
SQM025 Squamous Cell Carcinoma of the Nasal Cavity and Paranasal Sinuses 8 0.919
425
VLV001 Vulvar Keratinizing Squamous Cell Carcinoma 7 0.919
426
FLL014 Fallopian Tube Transitional Cell Carcinoma 13 0.915
427
OVR033 Ovary Papillary Carcinoma 11 0.915
428
NNP009 Non-Papillary Transitional Cell Carcinoma of the Bladder 9 0.915
429
RNL088 Renal Cell Carcinoma Associated with Neuroblastoma 9 0.915
430
c LNG003 Lung Carcinoma in Situ 9 0.915
431
c LPC001 Lip Carcinoma in Situ 7 0.915
432
CRV015 Cervical Large Cell Neuroendocrine Carcinoma 7 0.915
433
VLV006 Vulva Verrucous Carcinoma 7 0.915
434
OVR022 Ovary Mixed Epithelial Carcinoma 5 0.915
435
RCT008 Rectosigmoid Junction Neoplasm 30 0.910
436
THY017 Thymus Sarcomatoid Carcinoma 13 0.910
437
HLR004 Hilar Cholangiocellular Carcinoma 12 0.910
438
BSP002 Basophilic Carcinoma 10 0.910
439
BLD007 Bile Duct Signet Ring Cell Carcinoma 10 0.910
440
AMP004 Ampulla of Vater Adenosquamous Carcinoma 9 0.910
441
AMP006 Ampulla of Vater Squamous Cell Carcinoma 8 0.910
442
NNN004 Non-Invasive Bladder Urothelial Carcinoma 8 0.910
443
NNC014 Non-Central Nervous System-Localized Embryonal Carcinoma 6 0.910
444
GLS005 Glassy Cell Variant Cervical Adenosquamous Carcinoma 6 0.910
445
NPP001 Nipple Duct Carcinoma 6 0.910
446
CRV024 Cervical Adenoid Basal Carcinoma 5 0.910
447
ASB002 Asbestos-Related Lung Carcinoma 25 0.906
448
NPP003 Nipple Neoplasm 10 0.906
449
CRC038 Carcinoma of Stomach, Salivary Gland Type 8 0.906
450
CRC037 Carcinoma of Esophagus, Salivary Gland Type 8 0.906
451
BRS013 Borst-Jadassohn Intraepidermal Carcinoma 7 0.906
452
SQM019 Squamous Cell Carcinoma of the Small Intestine 7 0.906
453
SQM016 Squamous Cell Carcinoma of Gallbladder and Extrahepatic Biliary Tract 7 0.906
454
c ORL001 Oral Cavity Carcinoma in Situ 7 0.906
455
ACN009 Acantholytic Variant Squamous Cell Breast Carcinoma 7 0.906
456
CLM001 Columnar Cell Variant Papillary Carcinoma 7 0.906
457
c LNG006 Lung Occult Large Cell Carcinoma 7 0.906
458
PPL043 Papillary Carcinoma of the Cervix Uteri 7 0.906
459
ADN060 Adenoid Cystic Carcinoma of the Corpus Uteri 6 0.906
460
CLR016 Clear Cell Variant Infiltrating Bladder Urothelial Carcinoma 6 0.906
461
BRS024 Breast Large Cell Neuroendocrine Carcinoma 6 0.906
462
BLD011 Bladder Verrucous Squamous Cell Carcinoma 6 0.906
463
BLD013 Bladder Urachal Squamous Cell Carcinoma 6 0.906
464
MCR006 Micropapillary Variant Infiltrating Bladder Urothelial Carcinoma 6 0.906
465
MCR008 Microcystic Variant Infiltrating Bladder Urothelial Carcinoma 6 0.906
466
PSD011 Pseudovascular Skin Squamous Cell Carcinoma 6 0.906
467
LPD005 Lipid-Cell Variant Infiltrating Bladder Urothelial Carcinoma 6 0.906
468
NST001 Nested Variant Infiltrating Bladder Urothelial Carcinoma 6 0.906
469
PLS004 Plasmacytoid Variant Infiltrating Bladder Urothelial Carcinoma 6 0.906
470
ACN006 Acinic Cell Breast Carcinoma 6 0.906
471
ADN004 Adenosquamous Breast Carcinoma 6 0.906
472
BRS028 Breast Columnar Cell Mucinous Carcinoma 6 0.906
473
LRG004 Large Cell Keratinizing Variant Squamous Cell Breast Carcinoma 6 0.906
474
INF024 Infiltrating Bladder Lymphoepithelioma-Like Carcinoma 6 0.906
475
PNS011 Penis Verrucous Carcinoma 6 0.906
476
SPN037 Spindle Cell Variant Squamous Cell Breast Carcinoma 6 0.906
477
PLM024 Pulmonary Type Ovarian Small Cell Carcinoma 6 0.906
478
HRD003 Hereditary Conventional Renal Cell Carcinoma 5 0.906
479
GLL010 Gallbladder Mucinous Carcinoma 5 0.906
480
BLD004 Bladder Urachal Urothelial Carcinoma 5 0.906
481
BLD012 Bladder Urothelial Papillary Carcinoma 5 0.906
482
BLD050 Bladder Urachal Carcinoma 5 0.906
483
PLN004 Plantar Verrucous Skin Carcinoma 5 0.906
484
SQM017 Squamous Cell Carcinoma of Liver and Intrahepatic Biliary Tract 5 0.906
485
UND010 Undifferentiated Carcinoma of Liver and Intrahepatic Biliary Tract 5 0.906
486
CRV008 Cervical Basaloid Squamous Cell Carcinoma 5 0.906
487
PRS028 Prostatic Urethra Urothelial Carcinoma 5 0.906
488
RCT001 Rectum Sarcomatoid Carcinoma 5 0.906
489
LPD002 Lipid-Rich Breast Carcinoma 5 0.906
490
PNS001 Penis Non-Invasive Verrucous Carcinoma 5 0.906
491
PNS003 Penis Basaloid Carcinoma 5 0.906
492
PNS006 Penis Papillary Carcinoma 5 0.906
493
PPL042 Papillary Carcinoma of the Corpus Uteri 5 0.906
494
MXD021 Mixed Epithelial/mesenchymal Metaplastic Breast Carcinoma 5 0.906
495
SBC008 Sebaceous Breast Carcinoma 5 0.906
496
SBC013 Sebaceous Basal Cell Carcinoma 5 0.906
497
c PHR001 Pharynx Carcinoma in Situ 5 0.906
498
CRV027 Cervical Lymphoepithelioma-Like Carcinoma 4 0.906
499
CRV020 Cervical Non-Keratinizing Squamous Cell Carcinoma 4 0.906
500
URT005 Urethral Verrucous Carcinoma 4 0.906
501
VLV028 Vulvar Non-Keratinizing Squamous Cell Carcinoma 4 0.906
502
INT007 Intermediate Coronary Syndrome 55 0.900
503
SPR001 Superficial Urinary Bladder Cancer 29 0.900
504
PRS015 Prostate Signet Ring Cell Adenocarcinoma 13 0.900
505
OST141 Osteoclastic Giant Cell Tumor of Pancreas 13 0.900
506
ADM002 Adamantinoid Basal Cell Epithelioma 11 0.893
507
HLR001 Hilar Lung Neoplasm 10 0.893
508
CLT001 Clitoris Cancer 10 0.893
509
MXD043 Mixed Mucinous and Nonmucinous Bronchioloalveolar Adenocarcinoma 10 0.893
510
AMP005 Ampullary Signet Ring Cell Adenocarcinoma 9 0.893
511
EKR001 Eukaryotic Translation Elongation Factor 1 Alpha-1-Like 14 8 0.893
512
P FML321 Familial Stomach Cancer 8 0.893
513
RGN001 Regional Ureteric Cancer 7 0.893
514
PNC051 Pancreatic Cancer, Childhood 6 0.893
515
STM011 Stomach Cancer, Childhood 5 0.893
516
SQM022 Squamous Cell Carcinoma of the Larynx 45 0.875
517
P CRV035 Cervical Cancer 72 0.844
518
INT079 Intrahepatic Cholangiocarcinoma 60 0.830
519
SQM023 Squamous Cell Carcinoma of the Oropharynx 44 0.825
520
ORL011 Oral Cancer 60 0.809
521
CLR112 Clear Cell Papillary Renal Cell Carcinoma 27 0.806
522
OVR094 Ovarian Epithelial Cancer 46 0.799
523
P ORL007 Oral Cavity Cancer 59 0.792
524
PNC015 Pancreatic Acinar Cell Adenocarcinoma 35 0.792
525
CRV026 Cervical Clear Cell Adenocarcinoma 30 0.771
526
SQM021 Squamous Cell Carcinoma of the Hypopharynx 42 0.770
527
END075 Endocervical Adenocarcinoma 36 0.766
528
GLS012 Glassy Cell Carcinoma of the Cervix 29 0.766
529
TBL003 Tubular Adenocarcinoma 43 0.761
530
CRC034 Carcinoma Showing Thymus-Like Differentiation 24 0.750
531
SMT003 Somatostatinoma 54 0.745
532
ANS011 Anus Cancer 46 0.743
533
FML005 Female Reproductive Endometrioid Cancer 34 0.743
534
DDN010 Duodenum Cancer 46 0.733
535
BLD019 Bile Duct Cystadenocarcinoma 31 0.733
536
BRS058 Breast Myoepithelial Neoplasm 25 0.731
537
MCN021 Mucinous Bronchioloalveolar Adenocarcinoma 24 0.731
538
P END039 Endodermal Sinus Tumor 44 0.730
539
NRN006 Neuroendocrine Carcinoma of the Cervix 14 0.730
540
SRS001 Serous Cystadenocarcinoma 55 0.728
541
BRK001 Brooke-Spiegler Syndrome 45 0.726
542
OVR011 Ovarian Mucinous Adenocarcinoma 28 0.722
543
APP010 Appendix Cancer 40 0.720
544
HYP082 Hypopharynx Cancer 47 0.718
545
c SPR009 Sporadic Breast Cancer 47 0.718
546
P SML016 Small Intestine Cancer 52 0.716
547
THY092 Thymic Neuroendocrine Carcinoma 13 0.714
548
TBL026 Tubulocystic Renal Cell Carcinoma 13 0.714
549
SCL043 Sclerosing Mucoepidermoid Carcinoma with Eosinophilia 13 0.714
550
P PHR004 Pharynx Cancer 46 0.712
551
END035 Endocrine Gland Cancer 48 0.706
552
P URT040 Urethral Cancer 24 0.699
553
ACQ048 Acquired Cystic Disease-Associated Renal Cell Carcinoma 12 0.699
554
TMR016 Tumor Suppressor Gene on Chromosome 11 42 0.696
555
c URT035 Urethral Benign Neoplasm 27 0.696
556
P THY032 Thyroiditis 56 0.692
557
LYM100 Lymphoepithelial-Like Carcinoma 10 0.691
558
TRT001 Teratocarcinoma 41 0.688
559
ECC001 Eccrine Papillary Adenocarcinoma 23 0.683
560
FLL003 Fallopian Tube Endometrioid Adenocarcinoma 32 0.680
561
EPT007 Epithelial Malignant Thymoma 27 0.680
562
END032 Endometrial Clear Cell Adenocarcinoma 30 0.676
563
OVR062 Ovary Serous Adenocarcinoma 27 0.676
564
RMB001 Rombo Syndrome 20 0.676
565
c RNL034 Renal Cell Carcinoma 4 12 0.676
566
RJS001 Ruijs-Aalfs Syndrome 22 0.673
567
MXD042 Mixed Fibrolamellar Hepatocellular Carcinoma 9 0.673
568
KLT001 Klatskin's Tumor 47 0.669
569
TNS004 Tonsil Cancer 38 0.669
570
SQM024 Squamous Cell Carcinoma of the Salivary Glands 14 0.669
571
MXL008 Maxillary Sinus Cancer 27 0.662
572
PPL015 Papillary Thymic Adenocarcinoma 15 0.662
573
c KDN012 Kidney Carcinoma in Situ 7 0.657
574
PNC020 Pancreatic Solid Pseudopapillary Carcinoma 7 0.657
575
BLD001 Bile Duct Carcinoma in Situ 6 0.657
576
c INT019 Intestine Carcinoma in Situ 6 0.657
577
c INV003 Invasive Malignant Thymoma 32 0.652
578
GLL009 Gallbladder Signet Ring Cell Adenocarcinoma 12 0.652
579
NRN039 Neuroendocrine Carcinoma of Salivary Glands, Sensorineural Hearing Loss, and Enamel Hypoplasia 11 0.652
580
CWP002 Cowper Gland Carcinoma 10 0.652
581
ANL003 Anal Buschke-Lowenstein Tumor 8 0.652
582
c RNL033 Renal Carcinoma, Familial 5 0.652
583
BRN115 Bronchus Mucoepidermoid Carcinoma 5 0.652
584
MDL026 Medullary Colon Carcinoma 5 0.652
585
TRC090 Trachea Mucoepidermoid Carcinoma 5 0.652
586
ECC010 Eccrine Mucinous Carcinoma 2 0.652
587
HRT007 Heart Cancer 46 0.647
588
INS022 in Situ Pulmonary Adenocarcinoma 29 0.647
589
URC004 Urachal Cancer 18 0.647
590
c THY117 Thyroid Cancer, Nonmedullary, 3 14 0.647
591
c LNG001 Lung Clear Cell Carcinoma 8 0.647
592
BSL003 Basaloid Lung Carcinoma 7 0.647
593
CRM003 Ceruminous Carcinoma 7 0.647
594
LYM108 Lymph Node Adenoid Cystic Carcinoma 6 0.647
595
LTT003 Littre Gland Carcinoma 6 0.647
596
GLS017 Glassy Cell Carcinoma of the Cervix Uteri 6 0.647
597
PGM025 Pigmentation Defects-Palmoplantar Keratoderma-Skin Carcinoma Syndrome 6 0.647
598
UTR009 Uterus Carcinoma in Situ 5 0.647
599
FML007 Familiar Fallopian Tube Carcinoma 5 0.647
600
LYM013 Lymphoma-Like Variant Infiltrating Bladder Urothelial Carcinoma 5 0.647
601
MDR005 Moderately-Differentiated Thymic Neuroendocrine Carcinoma 5 0.647
602
c PNC021 Pancreatic Invasive Intraductal Papillary-Mucinous Carcinoma 5 0.647
603
PNC030 Pancreatic Non-Invasive Intraductal Papillary-Mucinous Carcinoma 5 0.647
604
PRL043 Poorly Differentiated Thymic Neuroendocrine Carcinoma 5 0.647
605
WLL020 Well-Differentiated Thymic Neuroendocrine Carcinoma 5 0.647
606
AFL001 Aflatoxins-Related Hepatocellular Carcinoma 4 0.647
607
CLS003 Classic Variant of Chromophobe Renal Cell Carcinoma 4 0.647
608
CRC002 Carcinoma Arising in Nasal Papillomatosis 4 0.647
609
SBL007 Sublingual Gland Adenoid Cystic Carcinoma 4 0.647
610
FML019 Familiar Ovarian Carcinoma 4 0.647
611
INF015 Infiltrating Ureter Transitional Cell Carcinoma 4 0.647
612
PNS005 Penis Mixed Squamous Cell Carcinoma 4 0.647
613
VLV027 Vulvar Keratoacanthoma-Like Carcinoma 4 0.647
614
GLL001 Gall Bladder Carcinoma in Situ 3 0.647
615
c BRN001 Bronchus Carcinoma in Situ 3 0.647
616
INF035 Infiltrating Renal Pelvis Transitional Cell Carcinoma 3 0.647
617
CRC008 Carcinoma of the Vocal Tract 2 0.647
618
CRC009 Carcinoma of Unknown Primary Site, Childhood 2 0.647
619
PRT017 Peritoneal Serous Papillary Adenocarcinoma 20 0.640
620
CHL124 Childhood Ovarian Cancer 5 0.640
621
ADR014 Adrenal Medulla Cancer 29 0.632
622
FLL022 Fallopian Tube Clear Cell Adenocarcinoma 15 0.632
623
HPT005 Hepatic Flexure Cancer 15 0.632
624
SPR037 Supraglottic Laryngeal Cancer 13 0.632
625
EPG001 Epiglottis Neoplasm 12 0.632
626
NNN002 Noninvasive Malignant Thymoma 11 0.632
627
BLD002 Bile Duct Mucinous Adenocarcinoma 10 0.632
628
BLD006 Bile Duct Clear Cell Adenocarcinoma 10 0.632
629
MLG047 Malignant Thyroid Stimulating Hormone Producing Neoplasm of Pituitary Gland 8 0.632
630
SLV014 Salivary Gland Type Cancer of the Breast 8 0.632
631
PPL010 Papillary Follicular Thyroid Adenocarcinoma 8 0.632
632
CHL048 Childhood Teratocarcinoma of the Testis 7 0.632
633
JWT001 Jewett-Marshall Bladder Cancer 7 0.632
634
TRB001 Trabecular Follicular Adenocarcinoma 6 0.632
635
TST009 Testis Refractory Cancer 6 0.632
636
CRV001 Cervical Endometrioid Adenocarcinoma 6 0.632
637
EXT002 Extrahepatic Bile Duct Small Cell Adenocarcinoma 6 0.632
638
RZC001 Ruzicka Goerz Anton Syndrome 4 0.632
639
P ESP024 Esophagitis 64 0.534
640
P ADN016 Adenocarcinoma 71 0.506
641
NSP002 Nasopharyngitis 46 0.426
642
P LRY019 Laryngitis 57 0.419
643
PRS047 Prostatitis 59 0.418
644
P CRV039 Cervicitis 49 0.404
645
P HPT021 Hepatitis 75 0.384
646
c BLD140 Blood Group, I System 37 0.334
647
P PNC044 Pancreatitis 64 0.331
648
ADN002 Adenoiditis 40 0.326
649
END072 Endotheliitis 46 0.324
650
ADN018 Adenoma 63 0.306
651
P LVR013 Liver Disease 76 0.305
652
c HPT016 Hepatitis B 68 0.243
653
URN009 Urinary System Disease 58 0.233
654
P KDN018 Kidney Disease 69 0.229
655
HYP266 Hypoxia 61 0.227
656
PRT036 Peritonitis 67 0.196
657
MLN008 Melanoma 72 0.186
658
c HPT001 Hepatitis C 73 0.182
659
PPL022 Papilloma 58 0.180
660
ALP072 Alpha-Fetoprotein Deficiency 32 0.173
661
PHR003 Pharyngitis 59 0.171
662
PLM014 Pleomorphic Adenoma 55 0.163
663
P LYM118 Lymphoma 71 0.162
664
AGN016 Aging 65 0.162
665
LVR012 Liver Cirrhosis 73 0.161
666
KRT009 Keratosis 53 0.152
667
P TRT010 Teratoma 53 0.147
668
c HPT073 Hepatitis C Virus 73 0.145
669
NSP003 Nasopharyngeal Disease 34 0.143
670
P KRT005 Keratoacanthoma 49 0.141
671
ONC007 Oncocytoma 48 0.139
672
CHR008 Choroiditis 47 0.135
673
P ACT008 Actinic Keratosis 56 0.134
674
THR024 Thrombosis 61 0.130
675
P CYS017 Cystic Teratoma 40 0.128
676
SRC014 Sarcoma 68 0.126
677
P LKM002 Leukemia 75 0.125
678
LKP003 Leukoplakia 42 0.124
679
P RTN024 Retinoblastoma 76 0.123
680
ESP023 Esophageal Disease 58 0.122
681
P HYP726 Hypercalcemia, Infantile, 1 57 0.122
682
BRS051 Breast Disease 67 0.120
683
P ANR048 Aniridia 1 68 0.119
684
ANR038 Anorexia Nervosa 1 21 0.119
685
BLD137 Blood Group--Ahonen 17 0.119
686
P THY023 Thymoma 65 0.117
687
ANG018 Angiomyolipoma 50 0.116
688
VRL011 Viral Infectious Disease 64 0.115
689
CMP080 Complement Hyperactivation, Angiopathic Thrombosis, and Protein-Losing Enteropathy 40 0.115
690
CHR603 Chronic Enteropathy Associated with Slco2a1 Gene 21 0.113
691
CLR108 Colorectal Adenoma 60 0.111
692
P MLT074 Multiple Endocrine Neoplasia 55 0.111
693
P RNL017 Renal Oncocytoma 49 0.111
694
NRN002 Neuronitis 43 0.109
695
ORL012 Oral Leukoplakia 45 0.108
696
MCS002 Mucositis 61 0.106
697
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 40 0.104
698
c THY107 Thymoma, Familial 34 0.104
699
P ART153 Arthrochalasia Ehlers-Danlos Syndrome 21 0.103
700
P INT068 Intestinal Disease 65 0.102
701
P CRV031 Cervical Adenocarcinoma 55 0.102
702
GTR002 Goiter 53 0.102
703
DDN006 Duodenitis 46 0.102
704
P HYP086 Hypothyroidism 62 0.101
705
MDS022 Mediastinitis 44 0.101
706
HPT082 Hepatic Adenomas, Familial 52 0.100
707
EWN002 Ewing's Family of Tumors 49 0.100
708
HRS011 Horseshoe Kidney 35 0.099
709
CYS014 Cystadenocarcinoma 51 0.097
710
RCT017 Rectal Disease 38 0.097
711
PRT018 Portal Vein Thrombosis 50 0.096
712
VNH007 Von Hippel-Lindau Syndrome 72 0.096
713
GST050 Gastrointestinal System Disease 66 0.095
714
GND003 Gonadal Disease 32 0.095
715
CLT003 Colitis 63 0.095
716
BLD044 Bladder Disease 55 0.095
717
CYS009 Cystadenoma 44 0.095
718
CRV045 Cervical Intraepithelial Neoplasia 43 0.095
719
P HYP069 Hyperparathyroidism 58 0.094
720
PRN039 Paraneoplastic Syndromes 35 0.094
721
P UTR058 Uterine Anomalies 55 0.093
722
P END044 Endometriosis 71 0.093
723
c HPT003 Hepatitis a 63 0.093
724
P OVR049 Ovarian Disease 58 0.092
725
INV006 Inverted Papilloma 36 0.092
726
LNT001 Linitis Plastica 36 0.092
727
CHL067 Cholecystitis 58 0.091
728
BRR014 Barrett Esophagus 64 0.090
729
ULC004 Ulcerative Colitis 80 0.089
730
ALR002 Al-Raqad Syndrome 30 0.089
731
INS024 Insulin-Like Growth Factor I 83 0.089
732
EPD016 Epidermolysis Bullosa 57 0.088
733
CLN019 Colonic Disease 55 0.088
734
MXD023 Mixed Cell Type Cancer 41 0.088
735
VGN023 Vaginitis 59 0.087
736
PPL018 Papillary Adenocarcinoma 47 0.087
737
LMY003 Leiomyomatosis 45 0.087
738
P MYC084 Mycobacterium Tuberculosis 1 69 0.086
739
P PHC003 Pheochromocytoma 72 0.086
740
VLV044 Vulvar Intraepithelial Neoplasia 40 0.086
741
CNN003 Conn's Syndrome 70 0.085
742
ALP042 Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity 63 0.085
743
c VRL010 Viral Hepatitis 59 0.085
744
BRN106 Burns 57 0.084
745
MMM001 Mammary Paget's Disease 51 0.084
746
SWT002 Sweat Gland Cancer 35 0.084
747
CLR109 Colorectal Adenocarcinoma 54 0.084
748
EPD001 Epidermodysplasia Verruciformis 52 0.084
749
P LCH002 Lichen Planus 58 0.083
750
UTR033 Uterine Corpus Cancer 51 0.083
751
c CLL013 Cell Type Cancer 37 0.083
752
P GST044 Gastritis 61 0.083
753
FXF002 Fox-Fordyce Disease 40 0.083
754
P FML011 Familial Adenomatous Polyposis 71 0.082
755
PRT029 Parathyroid Adenoma 50 0.082
756
LCH009 Lichen Sclerosus 45 0.082
757
FLL031 Follicular Adenoma 41 0.082
758
MCR019 Microglandular Adenosis 39 0.081
759
P LPS004 Lupus Erythematosus 69 0.081
760
SKN019 Skin Melanoma 63 0.081
761
BRN105 Burn Scar 39 0.080
762
P LNG064 Lung Cancer Susceptibility 3 64 0.079
763
UTR024 Uterine Carcinosarcoma 57 0.079
764
P PRT096 Peritoneal Mesothelioma 54 0.079
765
THY030 Thyroid Gland Disease 51 0.079
766
MCN008 Mucinous Cystadenocarcinoma 41 0.078
767
DRM013 Dermoid Cyst 43 0.077
768
P PNM007 Pneumonia 70 0.076
769
P PRG013 Paraganglioma 57 0.076
770
THY106 Thyroglossal Duct Cyst, Familial 25 0.076
771
PTZ001 Peutz-Jeghers Syndrome 70 0.075
772
GST040 Gastric Adenocarcinoma 60 0.075
773
P TRC086 Trichohepatoenteric Syndrome 1 54 0.075
774
P CRB059 Cerebellar Degeneration 40 0.075
775
c PRM023 Pre-Malignant Neoplasm 33 0.075
776
P XRD010 Xeroderma Pigmentosum, Variant Type 62 0.074
777
GYN001 Gynecomastia 47 0.074
778
BWN006 Bowen's Disease 35 0.074
779
TNS005 Tonsillitis 61 0.073
780
P SNS014 Sinusitis 62 0.072
781
P GLM045 Glioma 61 0.072
782
P GST049 Gastrointestinal System Cancer 60 0.072
783
HMN009 Hemangioblastoma 56 0.072
784
c LNG031 Lung Benign Neoplasm 46 0.072
785
P HRD009 Hereditary Wilms' Tumor 46 0.072
786
LRY017 Laryngeal Disease 38 0.072
787
NCR003 Necrotizing Sialometaplasia 36 0.072
788
P TBR001 Tuberous Sclerosis 69 0.071
789
c PRM005 Primary Hyperparathyroidism 59 0.071
790
PLY040 Polymorphous Low-Grade Adenocarcinoma 42 0.071
791
PNC002 Pancreatic Mucinous Cystadenoma 38 0.071
792
GST019 Gastrointestinal Stromal Tumor 74 0.071
793
c ADN012 Adenocarcinoma in Situ 45 0.071
794
P STR021 Struma Ovarii 40 0.071
795
P RNG031 Ring Chromosome Y Syndrome 29 0.071
796
BLR005 Biliary Papillomatosis 36 0.070
797
c MLT151 Multiple Mitochondrial Dysfunctions Syndrome 5 36 0.070
798
P HRP006 Herpes Simplex 70 0.069
799
c MNN043 Meningioma, Familial 69 0.069
800
SKN016 Skin Disease 68 0.069
801
PNC041 Pancreatic Ductal Adenocarcinoma 67 0.069
802
AML029 Ameloblastoma 51 0.069
803
P PRK001 Porokeratosis 49 0.069
804
OVR054 Ovarian Mucinous Neoplasm 34 0.069
805
PRK066 Parkinsonism with Spasticity, X-Linked 31 0.069
806
PNC018 Pancreatic Serous Cystadenoma 30 0.069
807
P LFR001 Li-Fraumeni Syndrome 72 0.068
808
PNC034 Pancreas Disease 59 0.068
809
PSD007 Pseudomyxoma Peritonei 54 0.068
810
P OBS001 Obstructive Jaundice 53 0.068
811
DSC009 Discoid Lupus Erythematosus 48 0.068
812
FML038 Female Reproductive Organ Cancer 42 0.068
813
c MLG036 Malignant Spiradenoma 31 0.068
814
P AST007 Astrocytoma 66 0.068
815
MTH009 Mouth Disease 64 0.068
816
c RCS002 Recessive Dystrophic Epidermolysis Bullosa 55 0.068
817
THR004 Thrombocytosis 55 0.067
818
c RTN162 Retinitis Pigmentosa 2 50 0.067
819
PRS129 Prostatic Hyperplasia, Benign 47 0.067
820
PGT003 Paget Disease, Extramammary 44 0.067
821
MLG098 Malignant Mixed Mullerian Tumor 37 0.067
822
c EPS039 Episodic Pain Syndrome, Familial, 1 33 0.067
823
OCL033 Oculocerebral Syndrome with Hypopigmentation 31 0.067
824
RCT020 Rectum Adenocarcinoma 25 0.067
825
GLB002 Glioblastoma 74 0.066
826
P NRB001 Neuroblastoma 73 0.066
827
P DRM010 Dermatomyositis 65 0.066
828
CHR072 Chordoma 61 0.066
829
CRC006 Carcinoid Syndrome 59 0.066
830
LMY002 Leiomyoma 58 0.066
831
ORL004 Oral Submucous Fibrosis 56 0.066
832
STM006 Stomach Disease 52 0.066
833
SMN007 Seminoma 49 0.066
834
DYS073 Dysphagia 47 0.066
835
SYN046 Syndrome of Inappropriate Antidiuretic Hormone 44 0.066
836
URT001 Urethritis 44 0.066
837
OVR060 Ovary Epithelial Cancer 35 0.066
838
MDD008 Middle Ear Adenoma 23 0.066
839
DRM006 Dermatitis 67 0.065
840
ANG020 Angiosarcoma 57 0.065
841
ORL013 Oral Lichen Planus 51 0.065
842
MLG076 Malignant Ovarian Surface Epithelial-Stromal Neoplasm 43 0.065
843
SPP011 Suppression of Tumorigenicity 12 41 0.065
844
SCL017 Sclerosing Hemangioma 41 0.065
845
END011 Endometriosis of Ovary 41 0.065
846
MLG012 Malignant Epithelial Mesothelioma 34 0.065
847
PNC033 Pancreas Adenocarcinoma 63 0.064
848
HPT022 Hepatoblastoma 55 0.064
849
PLM032 Pulmonary Blastoma 54 0.064
850
PRS045 Prostatic Hypertrophy 51 0.064
851
P SPR013 Spiradenoma 39 0.064
852
VLV031 Vulva Adenocarcinoma 23 0.064
853
P HMN010 Hemangioma 61 0.064
854
LMB002 Lambert-Eaton Myasthenic Syndrome 58 0.064
855
P PTT006 Pituitary Adenoma 57 0.064
856
CLN015 Colon Adenocarcinoma 53 0.064
857
P EST001 Estrogen-Receptor Positive Breast Cancer 52 0.064
858
c WLM011 Wilms Tumor 6 44 0.064
859
P MLT008 Multinodular Goiter 44 0.064
860
P GRM010 Germ Cells Tumors 37 0.064
861
CYS015 Cystadenofibroma 30 0.064
862
VLV021 Vulval Paget's Disease 22 0.064
863
GNG013 Gingivitis 64 0.063
864
P GLM007 Glomerulonephritis 61 0.063
865
PTT037 Pituitary Tumors 49 0.063
866
SKN027 Skin Conditions 48 0.063
867
CLN044 Colon Adenoma 45 0.063
868
MCN003 Mucinous Ovarian Cystadenoma 20 0.063
869
P PSR002 Psoriasis 65 0.062
870
c MST023 Mesothelioma, Malignant 61 0.062
871
P LMY004 Leiomyosarcoma 59 0.062
872
P BRS044 Breast Adenocarcinoma 58 0.062
873
CRB009 Cerebritis 41 0.062
874
CRV069 Cervix Disease 39 0.062
875
ECC008 Eccrine Sweat Gland Neoplasm 26 0.062
876
ACQ007 Acquired Immunodeficiency Syndrome 65 0.061
877
P BRS053 Breast Fibroadenoma 48 0.061
878
OLF005 Olfactory Neuroblastoma 48 0.061
879
P OVR010 Ovarian Brenner Tumor 43 0.061
880
c CTR122 Cataract 5, Multiple Types 38 0.061
881
NSL003 Nasal Cavity Adenocarcinoma 37 0.061
882
c TRC078 Trichohepatoenteric Syndrome 2 34 0.061
883
PRN032 Paraneoplastic Cerebellar Degeneration 33 0.061
884
XNT001 Xanthogranulomatous Pyelonephritis 32 0.061
885
c GST048 Gastrointestinal System Benign Neoplasm 31 0.061
886
GST017 Gastric Tubular Adenocarcinoma 29 0.061
887
ADN027 Adenomyosis 57 0.060
888
SPS003 Spastic Diplegia 55 0.060
889
P CHL066 Cholangitis 52 0.060
890
END007 Endosalpingiosis 32 0.060
891
P BRS017 Breast Adenomyoepithelioma 27 0.060
892
INF021 Infant Gynecomastia 25 0.060
893
c LKM071 Leukemia, Chronic Lymphocytic 75 0.059
894
GLB015 Glioblastoma Multiforme 68 0.059
895
HLC007 Helicobacter Pylori Infection 64 0.059
896
NDL007 Nodular Goiter 50 0.059
897
GRN022 Granulosa Cell Tumor of the Ovary 41 0.059
898
BLN002 Balanitis Xerotica Obliterans 41 0.059
899
BWN003 Bowenoid Papulosis 37 0.059
900
ADN075 Adenomyoma 36 0.059
901
BLD045 Bladder Diverticulum 32 0.059
902
LPD007 Lipoadenoma 31 0.059
903
THY007 Thymus Lipoma 29 0.059
904
P AMY004 Amyloidosis 69 0.058
905
P NRP001 Neuropathy 63 0.058
906
P GRV001 Graves' Disease 62 0.058
907
P PYL005 Pyelonephritis 56 0.058
908
P ATR005 Atrophic Gastritis 51 0.058
909
MTR010 Mature Teratoma 46 0.058
910
CRV036 Cervical Carcinosarcoma 39 0.058
911
PRL042 Proliferating Trichilemmal Cyst 38 0.058
912
CYS003 Cystitis Cystica 32 0.058
913
IMM006 Immune System Organ Benign Neoplasm 25 0.058
914
ATY007 Atypical Follicular Adenoma 24 0.058
915
BDY004 Body Mass Index Quantitative Trait Locus 11 75 0.057
916
c CNG410 Congenital Heart Defects, Hamartomas of Tongue, and Polysyndactyly 53 0.057
917
c MLG002 Malignant Peritoneal Mesothelioma 51 0.057
918
GNG002 Ganglioneuroma 50 0.057
919
ADN020 Adenosarcoma 43 0.057
920
MGS001 Megaesophagus 42 0.057
921
HDR004 Hidradenoma 41 0.057
922
AMP009 Ampulla of Vater Adenocarcinoma 36 0.057
923
INT004 Intraneural Perineurioma 36 0.057
924
FLL029 Fallopian Tube Disease 35 0.057
925
END001 Endometrial Mucinous Adenocarcinoma 31 0.057
926
OVR017 Ovarian Cystic Teratoma 30 0.057
927
TRG001 Trigonitis 29 0.057
928
SNS004 Sensory Organ Benign Neoplasm 15 0.057
929
c MLT156 Multiple Endocrine Neoplasia, Type I 70 0.056
930
P BCL006 B-Cell Lymphomas 70 0.056
931
MLG077 Malignant Peripheral Nerve Sheath Tumor 59 0.056
932
SFT003 Soft Tissue Sarcoma 58 0.056
933
P PMP001 Pemphigus 55 0.056
934
VCC001 Vaccinia 50 0.056
935
BDY005 Body Mass Index Quantitative Trait Locus 9 49 0.056
936
BDY019 Body Mass Index Quantitative Trait Locus 18 48 0.056
937
c MLG081 Malignant Teratoma 46 0.056
938
BDY017 Body Mass Index Quantitative Trait Locus 14 46 0.056
939
BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.056
940
BDY010 Body Mass Index Quantitative Trait Locus 4 45 0.056
941
BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.056
942
SXC001 Sex Cord-Gonadal Stromal Tumor 43 0.056
943
KRT063 Keratocystic Odontogenic Tumor 43 0.056
944
ESP025 Esophagus Adenocarcinoma 42 0.056
945
PRT035 Peritoneum Cancer 42 0.056
946
BDY006 Body Mass Index Quantitative Trait Locus 8 42 0.056
947
BDY012 Body Mass Index Quantitative Trait Locus 7 42 0.056
948
SCR001 Secretory Meningioma 41 0.056
949
SPT007 Spitz Nevus 39 0.056
950
ATX038 Ataxia and Polyneuropathy, Adult-Onset 38 0.056
951
LRG016 Large Intestine Adenocarcinoma 37 0.056
952
WRT003 Warthin Tumor 37 0.056
953
BLD039 Bladder Adenocarcinoma 34 0.056
954
URT016 Urethral Diverticulum 31 0.056
955
UTR032 Uterine Body Mixed Cancer 31 0.056
956
MTN001 Metanephric Adenoma 31 0.056
957
c BRS046 Breast Benign Neoplasm 26 0.056
958
THR011 Thoracic Benign Neoplasm 25 0.056
959
BRN028 Brain Cancer 72 0.056
960
c MLG068 Malignant Glioma 66 0.056
961
P ENC004 Encephalitis 66 0.056
962
P SLV002 Salivary Gland Cancer 62 0.056
963
P OLG002 Oligodendroglioma 59 0.056
964
PRS042 Prostate Disease 56 0.056
965
P HYP076 Hyperthyroidism 56 0.056
966
BLD032 Bile Duct Adenocarcinoma 39 0.056
967
MNN008 Meningeal Melanomatosis 38 0.056
968
PNC019 Pancreatoblastoma 33 0.056
969
PPL001 Papillary Adenoma 33 0.056
970
NDL010 Nodular Hidradenoma 28 0.056
971
RTT005 Rete Testis Neoplasm 24 0.056
972
BLD163 Blood Group, Dombrock System 23 0.056
973
P MDL005 Medulloblastoma 76 0.055
974
HYP056 Hypoglycemia 62 0.055
975
SCH014 Schistosomiasis 62 0.055
976
MST005 Mastitis 56 0.055
977
END031 Endometrial Stromal Sarcoma 53 0.055
978
HST009 Histiocytoma 51 0.055
979
ANX004 Anoxia 49 0.055
980
EPT012 Epithelioid Sarcoma 47 0.055
981
FBR019 Fibromatosis 47 0.055
982
PST011 Pustulosis of Palm and Sole 47 0.055
983
THY009 Thyroid Lymphoma 46 0.055
984
CRD001 Cardiac Tamponade 45 0.055
985
GLM008 Glomus Tumor 43 0.055
986
BRR002 Barrett's Adenocarcinoma 43 0.055
987
ADP007 Adie Pupil 41 0.055
988
P BNG032 Benign Mesothelioma 39 0.055
989
ALP041 Alopecia, Neurologic Defects, and Endocrinopathy Syndrome 37 0.055
990
EXT027 Extrahepatic Bile Duct Adenocarcinoma 36 0.055
991
GST016 Gastric Signet Ring Cell Adenocarcinoma 35 0.055
992
MYS004 Myiasis 34 0.055
993
DDN009 Duodenal Obstruction 34 0.055
994
XNT002 Xanthogranulomatous Cholecystitis 33 0.055
995
END016 Endocervicitis 28 0.055
996
GLN006 Glandular Cystitis 18 0.055
997
P ART022 Arthritis 77 0.054
998
P PRP029 Porphyria 62 0.054
999
P LPS002 Liposarcoma 61 0.054
1000
P FBR017 Fibrosarcoma 61 0.054
1001
ACN002 Acanthosis Nigricans 60 0.054
1002
P PRT013 Portal Hypertension 59 0.054
1003
IMM158 Immune Suppression 57 0.054
1004
HYP063 Hypersplenism 49 0.054
1005
CRC014 Carcinoid Tumors, Intestinal 46 0.054
1006
SYR002 Syringocystadenoma Papilliferum 45 0.054
1007
INT253 Intestinal Benign Neoplasm 42 0.054
1008
P RPR003 Reproductive Organ Cancer 38 0.054
1009
APC005 Apocrine Sweat Gland Neoplasm 27 0.054
1010
INT015 Intracystic Papillary Adenoma 27 0.054
1011
c LRG002 Large Cell Acanthoma 27 0.054
1012
PLY150 Polykaryocytosis Inducer 20 0.054
1013
NRF026 Neurofibromatosis, Type Iv, of Riccardi 72 0.053
1014
NRF007 Neurofibroma 65 0.053
1015
HDR002 Hidradenitis Suppurativa 54 0.053
1016
PLM026 Pilomatrixoma 53 0.053
1017
SML036 Small Intestinal Adenocarcinoma 51 0.053
1018
GNG004 Ganglioglioma 51 0.053
1019
CHL056 Cheilitis 47 0.053
1020
HDR003 Hidradenitis 47 0.053
1021
c EST002 Estrogen-Receptor Negative Breast Cancer 44 0.053
1022
BLD063 Bile Duct Cysts 44 0.053
1023
HPT067 Hepatocellular Adenoma 43 0.053
1024
PRV003 Perivascular Epithelioid Cell Tumor 42 0.053
1025
P PRG002 Progesterone-Receptor Positive Breast Cancer 40 0.053
1026
CLR014 Clear Cell Adenoma 39 0.053
1027
c LKM004 Leukemia, B-Cell, Chronic 37 0.053
1028
THY024 Thymus Adenocarcinoma 27 0.053
1029
PPL013 Papillary Ependymoma 27 0.053
1030
ALP046 Alport Syndrome, X-Linked 74 0.052
1031
HSH003 Hashimoto Thyroiditis 67 0.052
1032
P HST010 Histiocytosis 60 0.052
1033
GRD007 Grade Iii Astrocytoma 56 0.052
1034
DSM007 Desmoplastic Small Round Cell Tumor 53 0.052
1035
c MLG074 Malignant Mesenchymoma 51 0.052
1036
c WLM018 Wilms Tumor 5 49 0.052
1037
c PLY146 Polycystic Liver Disease 1 45 0.052
1038
PLM018 Pulmonary Sclerosing Hemangioma 37 0.052
1039
PNC038 Pancreatic Cystadenocarcinoma 37 0.052
1040
OVR044 Ovarian Carcinosarcoma 36 0.052
1041
CRB022 Cerebellar Liponeurocytoma 36 0.052
1042
c SRF005 Surfactant Metabolism Dysfunction, Pulmonary, 3 35 0.052
1043
c LKM056 Leukemia, Chronic Lymphocytic 2 35 0.052
1044
P INT283 Integumentary System Cancer 33 0.052
1045
c SRF008 Surfactant Metabolism Dysfunction, Pulmonary, 4 32 0.052
1046
RTT004 Rete Testis Adenocarcinoma 25 0.052
1047
c BNG014 Benign Breast Adenomyoepithelioma 23 0.052
1048
c INT282 Integumentary System Benign Neoplasm 20 0.052
1049
MCN006 Mucinous Adenofibroma 15 0.052
1050
HPD002 Hepadnavirus Infection 14 0.052
1051
LYM133 Lymphoma, Hodgkin, Classic 78 0.051
1052
c TBR025 Tuberous Sclerosis 1 63 0.051
1053
PLS011 Plasmacytoma 60 0.051
1054
NNL002 Nonalcoholic Steatohepatitis 56 0.051
1055
SBP001 Subependymal Giant Cell Astrocytoma 50 0.051
1056
MDL002 Medulloepithelioma 46 0.051
1057
FBR003 Fibrous Histiocytoma 46 0.051
1058
PLM020 Pleomorphic Xanthoastrocytoma 43 0.051
1059
ACT093 Actinic Cheilitis 42 0.051
1060
MTG002 Mutagen Sensitivity 41 0.051
1061
ECC004 Eccrine Porocarcinoma 38 0.051
1062
PPL050 Papillary Tumor of the Pineal Region 36 0.051
1063
SHR059 Short Stature, Onychodysplasia, Facial Dysmorphism, and Hypotrichosis 33 0.051
1064
NPH001 Nephrogenic Adenoma 31 0.051
1065
CLL010 Cellular Ependymoma 24 0.051
1066
SMN006 Seminal Vesicle Tumor 23 0.051
1067
ADT002 Auditory System Cancer 21 0.051
1068
P MNN013 Meningitis 71 0.049
1069
LYM007 Lymphangioleiomyomatosis 68 0.049
1070
ISC004 Ischemia 66 0.049
1071
P RHB003 Rhabdomyosarcoma 61 0.049
1072
SRC027 Sarcoma, Synovial 58 0.049
1073
PNM008 Pneumothorax 57 0.049
1074
P PRM051 Primary Pigmented Nodular Adrenocortical Disease 56 0.049
1075
LYM027 Lymphopenia 56 0.049
1076
BLR006 Biliary Tract Disease 55 0.049
1077
RTN023 Retinitis 52 0.049
1078
ADR012 Adrenal Gland Disease 51 0.049
1079
CYS039 Cystic Kidney Disease 49 0.049
1080
CHR074 Choriocarcinoma 49 0.049
1081
P PRM001 Primary Cutaneous Amyloidosis 48 0.049
1082
SBP004 Subependymoma 46 0.049
1083
PYG006 Pyogenic Granuloma 45 0.049
1084
LYM024 Lymphatic System Disease 45 0.049
1085
CNT019 Central Neurocytoma 42 0.049
1086
PRG014 Progesterone Resistance 41 0.049
1087
ADR009 Adrenal Cortex Disease 40 0.049
1088
PNC006 Pancreatic Somatostatinoma 39 0.049
1089
OPT008 Optic Nerve Neoplasm 38 0.049
1090
P SRT003 Sertoli-Leydig Cell Tumor 38 0.049
1091
c PRG003 Progesterone-Receptor Negative Breast Cancer 37 0.049
1092
ATY002 Atypical Choroid Plexus Papilloma 37 0.049
1093
P GST047 Gastrointestinal Neuroendocrine Tumor 36 0.049
1094
CHR055 Chordoid Meningioma 32 0.049
1095
ANG019 Angiomyoma 29 0.049
1096
c ACT053 Acute Thyroiditis 29 0.049
1097
JJN007 Jejunal Adenocarcinoma 29 0.049
1098
MLG011 Malignant Biphasic Mesothelioma 29 0.049
1099
CRB030 Cerebellum Cancer 28 0.049
1100
ADN088 Adenoma of the Pancreas 27 0.049
1101
CTN010 Cutaneous Ganglioneuroma 26 0.049
1102
PRD001 Predominantly Cortical Thymoma 25 0.049
1103
LNG022 Lung Acinar Adenocarcinoma 19 0.049
1104
MYL069 Myeloma, Multiple 86 0.048
1105
P ATX030 Ataxia-Telangiectasia 80 0.048
1106
P THR014 Thrombocytopenia 65 0.048
1107
ERY003 Erythema Multiforme 60 0.048
1108
P PLY041 Polymyositis 57 0.048
1109
INT051 Intussusception 51 0.048
1110
P GNT008 Giant Cell Tumor 49 0.048
1111
CVR006 Cavernous Hemangioma 48 0.048
1112
DDF001 Dedifferentiated Liposarcoma 47 0.048
1113
PHC013 Phaeochromocytoma 44 0.048
1114
LMB024 Limbic Encephalitis 42 0.048
1115
TRP003 Triple-Receptor Negative Breast Cancer 38 0.048
1116
EXT052 Extraskeletal Ewing Sarcoma 37 0.048
1117
PRC010 Pericardial Mesothelioma 35 0.048
1118
INT016 Intraductal Papilloma 35 0.048
1119
MBM001 Meibomian Cyst 30 0.048
1120
EPT008 Epithelioid Malignant Peripheral Nerve Sheath Tumor 29 0.048
1121
CRB038 Cerebral Ventricle Cancer 26 0.048
1122
c CHR087 Chronic Cystitis 26 0.048
1123
SPR024 Supratentorial Cancer 26 0.048
1124
CRB040 Cerebrum Cancer 25 0.048
1125
CRN033 Cranial Nerve Malignant Neoplasm 25 0.048
1126
BRT012 Bartholin's Gland Adenoma 24 0.048
1127
CDQ003 Cauda Equina Neoplasm 24 0.048
1128
P CNT044 Central Nervous System Primitive Neuroectodermal Neoplasm 23 0.048
1129
VST005 Vestibular Gland Benign Neoplasm 23 0.048
1130
OLF004 Olfactory Nerve Neoplasm 22 0.048
1131
c VGN016 Vaginal Benign Neoplasm 15 0.048
1132
VGN010 Vaginal Tubulovillous Adenoma 14 0.048
1133
VGN015 Vaginal Adenoma 14 0.048
1134
P CNJ013 Conjunctivitis 67 0.04